Anup M.

Background

About Anup M.

I am a results-focused API marketing leader with 15 + years steering pharmaceutical sales across both Regulated and Non-Regulated arenas. At CTX Lifesciences I currently direct an INR 200 crore business, supplying formulators that serve strictly controlled markets—the US, EU, Canada—as well as fast-moving domestic and emerging economies. My specialty is market development: reading epidemiological data, patent cliffs, and reimbursement shifts early, then translating those signals into launch blueprints. I championed CTX’s timely entry into high-growth metabolic and cardiovascular therapies—linagliptin, dapagliflozin, apixaban, edoxaban, among others—securing plant capacity, aligning DMF filings with FDA / EMA timelines, and co-designing bioequivalence studies so customers could launch months ahead of rivals. These efforts generated sustained double-digit revenue and marked CTX as a forward-looking partner. Relationship management is equally central to my approach. I move beyond transactional selling to become a solution partner—whether resolving a polymorph shift that threatens tablet stability in tropical storage or restructuring deliveries to ease a client’s cash-flow crunch. The payoff: repeat-order ratios above 80 %, average contract tenures beyond five years, and a top-quartile Net Promoter Score. I have orchestrated cross-functional squads that brought 20 + APIs from lab to market, including niche neurology agents (safinamide, brexpiprazole) and advanced gastro therapies (vonoprazan). I ensure each molecule’s price-volume curve is realistic, patent landscapes are de-risked, and retrofit budgets stay tethered to addressable share—yielding more than INR 500 crore in cumulative revenue. I now seek a senior leadership role where I can scale global footprints, institute data-driven account planning, and align R&D pipelines with evolving therapeutic and reimbursement landscapes. Success, for me, is measured not only by top-line growth but by durable competitive advantage, agile supply chains, and the health outcomes our APIs ultimately enable. In short, I offer a rare blend of commercial acumen, technical fluency, and regulatory savvy—ready to propel a forward-thinking organization into its next chapter of sustainable, global growth.